Rhythm Pharmaceuticals, Inc. (RYTM) DCF Valuation

Rhythm Pharmaceuticals, Inc. (RYTM) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Rhythm Pharmaceuticals, Inc. (RYTM) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Rhythm Pharmaceuticals, Inc. (RYTM) valuation with this customizable DCF Calculator! Featuring real Rhythm Pharmaceuticals, Inc. (RYTM) financials and adjustable forecast inputs, you can test scenarios and uncover Rhythm Pharmaceuticals, Inc. (RYTM) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 3.2 23.6 77.4 116.1 174.2 261.3 392.0 588.0
Revenue Growth, % 0 0 0 649.46 227.56 50 50 50 50 50
EBITDA -145.2 -135.9 -68.5 -174.5 -168.5 -23.2 -34.8 -52.3 -78.4 -117.6
EBITDA, % 100 100 -2170.39 -738.28 -217.58 -20 -20 -20 -20 -20
Depreciation .8 .7 1.2 1.4 1.8 56.9 85.3 128.0 192.0 288.0
Depreciation, % 100 100 36.72 5.94 2.27 48.98 48.98 48.98 48.98 48.98
EBIT -146.0 -136.6 -69.6 -175.9 -170.2 -23.2 -34.8 -52.3 -78.4 -117.6
EBIT, % 100 100 -2207.1 -744.22 -219.85 -20 -20 -20 -20 -20
Total Cash 292.5 172.8 294.9 333.3 275.8 116.1 174.2 261.3 392.0 588.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 1.0 6.2 14.9
Account Receivables, % 100 100 32.5 26.33 19.2
Inventories .0 .0 .1 2.9 8.6 52.7 79.1 118.6 178.0 266.9
Inventories, % 100 100 3.52 12.34 11.14 45.4 45.4 45.4 45.4 45.4
Accounts Payable 10.4 4.9 5.7 4.8 4.9 75.9 113.8 170.7 256.0 384.1
Accounts Payable, % 100 100 181.9 20.29 6.31 65.32 65.32 65.32 65.32 65.32
Capital Expenditure -3.4 -.2 -5.4 -4.3 .0 -27.4 -41.2 -61.8 -92.6 -139.0
Capital Expenditure, % 100 100 -172.29 -18.11 -0.06070155 -23.63 -23.63 -23.63 -23.63 -23.63
Tax Rate, % -0.30633 -0.30633 -0.30633 -0.30633 -0.30633 -0.30633 -0.30633 -0.30633 -0.30633 -0.30633
EBITAT -139.7 -133.2 -68.0 -177.8 -170.7 -22.8 -34.2 -51.3 -77.0 -115.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -131.8 -138.3 -72.6 -189.6 -183.3 -16.2 -10.8 -16.2 -24.2 -36.3
WACC, % 14.74 14.75 14.75 14.76 14.76 14.75 14.75 14.75 14.75 14.75
PV UFCF
SUM PV UFCF -65.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -37
Terminal Value -291
Present Terminal Value -146
Enterprise Value -211
Net Debt -59
Equity Value -153
Diluted Shares Outstanding, MM 58
Equity Value Per Share -2.65

What You Will Get

  • Comprehensive RYTM Financials: Access to historical and projected data for precise valuation.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Dynamic calculations for intrinsic value and NPV.
  • Scenario Testing: Evaluate various scenarios to assess Rhythm Pharmaceuticals' future outlook.
  • User-Friendly Interface: Designed for professionals but easy for newcomers to navigate.

Key Features

  • Comprehensive Historical Data: Rhythm Pharmaceuticals' financial statements and pre-filled projections.
  • Customizable Variables: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Valuation: Instantly view Rhythm Pharmaceuticals' intrinsic value as calculations update live.
  • Insightful Visualizations: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file for Rhythm Pharmaceuticals, Inc. (RYTM).
  2. Step 2: Review the pre-filled financial data and forecasts specific to Rhythm Pharmaceuticals.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for informed investment decisions.

Why Choose This Calculator?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
  • Real-Time Feedback: Observe immediate updates to Rhythm Pharmaceuticals’ valuation as you tweak the inputs.
  • Preloaded Data: Comes equipped with Rhythm Pharmaceuticals’ actual financial metrics for swift evaluations.
  • Preferred by Experts: Utilized by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Healthcare Professionals: Understand the valuation of biopharmaceutical companies and apply it to real-world scenarios.
  • Researchers: Utilize advanced models in studies related to drug development and market strategies.
  • Investors: Evaluate your investment strategies and analyze the market performance of Rhythm Pharmaceuticals (RYTM).
  • Financial Analysts: Enhance your analysis with a customizable DCF model specifically designed for biotech firms.
  • Entrepreneurs: Learn from the valuation processes of established biopharmaceutical companies like Rhythm Pharmaceuticals (RYTM).

What the Template Contains

  • Historical Data: Includes Rhythm Pharmaceuticals' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Rhythm Pharmaceuticals' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Rhythm Pharmaceuticals' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

Es wurden keine passenden Produkte gefunden.